GlassScriptPhysician profile
Jonathan Cargo
NPI 1134154206
$137,947.34
in general payments reported to CMS, 2019-2025
16 companies · $33K in 2025
The $33K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $8,162 · 2021: $21K · 2022: $18K · 2023: $25K · 2024: $20K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $54K · Travel and Lodging: $9,718 · Food and Beverage: $7,850 · Consulting Fee: $5,700 · Entertainment: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $54,450.00 |
| Travel and Lodging | $9,717.74 |
| Food and Beverage | $7,849.99 |
| Consulting Fee | $5,700.00 |
| Entertainment | $209.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $93,023.26 | 2022-2025 | Infuse, Infuse Multifocal, Multi-Focal |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $40,513.94 | 2019-2021 | |
| Alcon Vision LLC | $1,762.15 | 2019-2025 | Total30, Precision7, Dailies Total1 |
| Coopervision INC. | $843.34 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Optos, INC. | $437.59 | 2021-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Lkc Technologies, INC. | $337.61 | 2023-2025 | |
| Glaukos Corporation | $274.72 | 2024 | Radius |
| Johnson & Johnson Vision Care, INC. | $152.53 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $132.34 | 2022 | |
| Genzyme Corporation | $122.03 | 2019 | |
| Allergan, INC. | $121.56 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $98.56 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $47.92 | 2022 | |
| Sight Sciences, INC. | $33.57 | 2020 | |
| Astellas Pharma US INC | $27.33 | 2024 | Izervay |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $18.89 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Cargo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.